Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Marshall Wace LLP Paul Marshall And Ian Wace | 949,425 | $28,397,301 | +341% | 0.04% |
2. | Millennium Management Israel Englander | 473,929 | $14,175,216 | -8% | 0% |
3. | Tang Capital Management Kevin C. Tang | 100,000 | $2,991,000 | 0.31% | |
4. | Hudson Bay Capital Management Sander Gerber | 90,000 | $2,691,900 | -6% | 0.01% |
5. | Two Sigma Advisors John Overdeck And David Siegel | 57,300 | $1,713,843 | 0% |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 15,614,510 | $497,165,998 | 0.19% | |
2. | 4,409,575 | $140,400,861 | 0% | |
3. | 4,057,922 | $129,650,575 | 0.02% | |
4. | 3,289,895 | $97,568,587 | 0.54% | |
5. | 2,369,331 | $75,439,498 | 0.01% |